5 Efficacy and Safety of Imatinib in Treatment of Pulmonary Arterial Hypertension(The Drug of Choice for Idiopathic Pulmonary Arterial Hypertension,Roundtable Discussion 5 (RT-5) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2009-03-01
著者
-
Matsubara Hiromi
Division Of Cardiology National Hospital Organization Okayama Medical Center
-
Matsubara Hiromi
Division Of Cardiology Okayama Medical Center
関連論文
- Cytokine Reducing Effect of Azelnidipine in Human Peripheral Blood Mononuclear Cells
- OJ-043 Inhibitory Effects of Simvastatin and Imatinib on PDGF-induced Proliferation and Migration of Smooth Muscle Cells Obtained from Patients with IPAH(OJ08,Pulmonary Circulation (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The
- OE-110 High-dose Epoprostenol Reverses Pulmonary Hypertension by Pulmonary Artery Smooth Muscle Cell Apoptosis in Patients with Idiopathic Pulmonary Arterial Hypertension(OE19,Pulmonary Circulation (H),Oral Presentation (English),The 73rd Annual Scientifi
- PJ-606 Pulmonary Veno-occlusive Disease : Acute Vasodilator Response and Prognosis(PJ102,Pulmonary Circulation 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Risk of Alveolar Hemorrhage in Patients with Primary Pulmonary Hypertension : Anticoagulation and Epoprostenol Therapy(Pulmonary Circulation 3 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Effects of Long-Acting Beraprost Sodium (TRK-100STP) in Japanese Patients With Pulmonary Arterial Hypertension
- Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 ECG in patients with Brugada syndrome
- Marked Hemodynamic Improvements by High-Dose Epoprostenol Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
- Recovery of Cardiac Function After Living-Donor Lung Transplantation in a Patient With Primary Pulmonary Hypertension
- PJ-607 Vascular Endothelial Growth Factor and Platelet Derived Growth Factor in Patients with Pulmonary Arterial Hypertension(PJ102,Pulmonary Circulation 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Societ
- PJ-516 Predictive Factors of Restenosis after Paclitaxel-Eluting Stent Implantation(PJ087,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PE-512 Prognostic Predictive Factor in Pulmonary Arterial Hypertension Patients Treated with Epoprostenol(PE086,Pulmonary Circulation (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-044 Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension : Better Alternative to Medical Therapy(OJ08,Pulmonary Circulation (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circ
- OE-109 Targeted Therapy Drug Imatinib Provided Beneficial Short-term Effect in Patients with Refractory Pulmonary Arterial Hypertension(OE19,Pulmonary Circulation (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulati
- Additional Effects of Bosentan in Patients With Idiopathic Pulmonary Arterial Hypertension Already Treated With High-Dose Epoprostenol
- OE-225 Structural Characteristics of Pulmonary Microvasculature in Patients with Pulmonary Hypertension(Pulmonary circulation(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-224 Pulmonary Arterial Augmentation Index Reflects Disease Severity in Patients with Pulmonary Arterial Hypertension(Pulmonary circulation(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Prevention of Catheter-Related Infections Using A Closed Hub System in Patients With Pulmonary Arterial Hypertension
- PJ-832 Epoprostenol Improves the Vasoreactivity to Oxygen in Patients with PAH(Pulmonary circulation-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-445 Negative Inotropic Effect Induced by Cyclic GMP Would be an Underlying Mechanism of Takotsubo Cardiomyopathy(Cardiomyopathy, basic/clinical-7, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- 1 Short and Long Term Effect of the Combination Therapy of Epoprostenol and Bosentan for Patients with Pulmonary Arterial Hypertension(Diagnosis and Treatment of Pulmonary Hypertension, The 71st Annual Scientific Meeting of the Japanese Circulation Societ
- PE-294 Application of Prostacyclin to Patients with Pulmonary Venoocclusive Disease and Pulmonary Capillary Hemangiomatosis(Pulmonary circulation-3 (H) PE49,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulatio
- OE-247 Acute Hemodynamic Effect of Bosentan in Patients with Idiopathic Pulmonary Arterial Hypertension Already Treated with Epoprostenol(Pulmonary circulation-1 (H) OE42,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Ja
- Three-dimensional Structure of Pulmonary Microvasculature in Patients with Primary Pulmonary Hypertension (Pulmonary Circulation 4 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Direct in vivo visualization of rat coronary capillary hemodynamics by intravital pencil lens-probe CCD videomicroscopy
- OE-297 Elevated Levels of 8-Hydroxy-2-Deoxyguanosine in Serum and Myocardium of Patients with Dilated Cardiomyopathy(Cardiomyopathy, Clinical 6 (M) : OE37)(Oral Presentation (English))
- Anti-inflammatory Effects of Long-lasting Locally-Delivered Human Recombinant Tissue Factor Pathway Inhibitor after Balloon Angioplasty
- Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium
- FRS-055 Beneficial Role of Hydroxyfasudil, a Specific Rho-kinase Inhibitor, on Ischemia-Reperfusion Injury in Canine Coronary Microvessels(Oxidative Stress, Autonomic Function and Peripheral Vascular Diseases (H) : FRS7)(Featured Research Session (English
- Cardiovascular Beneficial Effects of Electroacupuncture at Neiguan (PC-6) Acupoint in Anesthetized Open-Chest Dog
- Logistic Time Constant of Isometric Relaxation Force Curve of Ferret Ventricular Papillary Muscle : Reliable Index of Lusitropism
- Logistic Characterization of Left Ventricular Isovolumic Pressure-Time Curve
- PE-475 The Gender Difference of In-Hospital Mortality among Patients with Acute Myocardial Infarction in Japan(PE080,ACS/AMI (Clinical/Pathophysiology/Treatment/Basic), Angina Pectoris (Clinical) (IHD),Poster Session (English),The 73rd Annual Scientific M
- PJ-579 The Longer Pre-hospital Time Delay Resulted in Worse Prognosis in the Patients with Acute Myocardial Infarction from a Registry Database(Acute myocardial infarction, clinical(diagnosis/treatment)(11)(IHD),Poster Session(Japanese),The 72nd Annual Sc
- PJ-569 Genotype-Phenotype Correlation in Brugada Syndrome Detected by Using Two Drug-Induced Brugada Syndrome Models(PJ096,Arrhythmia, Others (Clinical/Pathophysiology) 4 (A),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
- Risk of Alveolar Hemorrhage in Patients With Primary Pulmonary Hypertension : Anticoagulation and Epoprostenol Therapy
- PE-442 Prednisolone Inhibits Proliferation of Pulmonary Artery Smooth Muscle Cells from Patients with Primary Pulmonary Hypertension(Peripheral Circulation/Vascular Disease 4(H) : PE75)(Poster Session (English))
- The Difference of Site Specific Inducibility of Polymorphic Ventricular Tachycardia / Ventricular Fibrillation in Patients with the Brugada Syndrome
- The Ventricular Arrhythmia induced by Pilsicainide in Patients with the Brugada Syndrome
- Left Ventricular Conduction Abnormality in the Brugada Syndrome
- FRS-047 Epicardial Ablation Eliminates Ventricular Arrhythmias in an Experimental Model of Brugada Syndrome(Novel Strategies for Arrhythmia(1)(A),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Aldosterone Synthesis and Cytokine Production in Human Peripheral Blood Mononuclear Cells
- Anti-inflammatory Effect of Spironolactone on Human Peripheral Blood Mononuclear Cells
- Epoprostenol Infusion Therapy Changes Angiographic Findings of Pulmonary Arteries in Patients With Idiopathic Pulmonary Arterial Hypertension
- 5 Scavenging Reactive Oxygen Species by Edaravone Preserves Coronary Microvascular Endothelial Function Myocardial eNOS Expression on Ischemia/Reperfusion Injury In Vivo Beating Canine Heart(Young Investigator's Award for International Students Finalists
- OJ-023 4-Hydroxy-2-nonenal-induced Calcium Overload via Reactive Oxygen Species in Isolated Rat Cardiac Myocytes(Heart failure, basic-2 (M) OJ4,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society
- Elevated Levels of Oxidative DNA Damage in Serum and Myocardium of Patients With Heart Failure
- The ratio of the atrial areas reflects the clinical status of patients with pulmonary arterial hypertension
- PJ-824 The Usefulness of the Ratio of Both Atrial Areas for Assessment of Therapeutic Effects on Patients with Pulmonary Arterial Hypertension(Pulmonary circulation-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- 5 Efficacy and Safety of Imatinib in Treatment of Pulmonary Arterial Hypertension(The Drug of Choice for Idiopathic Pulmonary Arterial Hypertension,Roundtable Discussion 5 (RT-5) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Acute Vasoreactivity Testing With Nicardipine in Patients With Pulmonary Arterial Hypertension
- Paroxysmal Supraventricular Tachycardia with Idiopathic Pulmonary Arterial Hypertension—A Case Report—
- Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension:– A Pilot Efficacy Trial –
- Acute Vasoreactivity Testing With Nicardipine in Patients With Pulmonary Arterial Hypertension
- Double-Blind, Placebo-Controlled Clinical Trial With a Rho-Kinase Inhibitor in Pulmonary Arterial Hypertension : A Pilot Efficacay Trial